2024-03-28T20:40:09Z
http://repoint.unil.ch/oaiprovider/
oai:serval.unil.ch:BIB_74AFB87DCACD
2024-03-23T02:32:17Z
serval:BIB_74AFB87DCACD
Sclérose en plaques: au-delà des traitements de première ligne [Multiple sclerosis: beyong first line therapies].
22675826
Schluep
M.
author
Du Pasquier
R.
author
article
review
2012
Revue Médicale Suisse
1660-9379
1660-9379
journal
8
339
946-949
Adjuvants, Immunologic/therapeutic use
Antibodies, Monoclonal, Humanized/therapeutic use
Choice Behavior
Combined Modality Therapy
Humans
Immunosuppressive Agents/therapeutic use
Immunotherapy
Multiple Sclerosis/drug therapy
Multiple Sclerosis/therapy
Patient Education as Topic
Propylene Glycols/therapeutic use
Sphingosine/analogs & derivatives
Sphingosine/therapeutic use
Therapies, Investigational/methods
Therapies, Investigational/utilization
fre
60_published
Publication types: English Abstract ; Journal Article ; ReviewPublication Status: ppublish